Valuation
MDGLMadrigal Pharmaceuticals Inc
StockNasdaqAmerika Birleşik DevletleriHealth careEU retail: available
1/10
Ratios vs sector
Medians of Health care companies in the same region (stocks and REITs).
| Metric | MDGL | Sector median | vs median |
|---|---|---|---|
| P/E | — | 28,8 · n=114 | — |
| P/B | 20,3 | 3,0 · n=196 | %574 above |
| P/S | 8,3 | 3,7 · n=202 | %123 above |
| EV/EBIT | — | 24,1 · n=103 | — |
| Free-cash-flow yield | — | %2,8 · n=187 | — |
| Dividend yield | %0,00 | %0,00 · n=215 | — |
| Return on equity | −%53,3 | %2,7 · n=193 | %2.106 below |
| Return on invested capital | −%53,8 | %3,5 · n=176 | %1.615 below |
| Gross margin | — | %62,5 · n=152 | — |
| Net debt / EBITDA | — | 1,19 · n=108 | — |
Value factor: 20 of 100 within the peer group. Full score breakdown →
Sector peers
The largest companies of the same sector and region.
| Instrument | P/E | P/B | EV/EBIT | Free-cash-flow yield | Dividend yield | Smart Score |
|---|---|---|---|---|---|---|
| LLYEli Lilly & Co | 42,6 | 33,6 | — | %1,6 | %0,6 | 6/10 |
| JNJJohnson & Johnson | 29,1 | 7,2 | — | %3,6 | %2,1 | 8/10 |
| ABBVAbbVie | 79,9 | — | 33,5 | %3,6 | %3,0 | 5/10 |
| MRKMerck | 114,6 | 8,7 | — | %4,4 | %2,3 | 8/10 |
| UNHUnitedHealth | 25,1 | 3,4 | 18,6 | %6,7 | %2,3 | 9/10 |
| TMOThermo Fisher Scientific | 35,7 | 4,7 | 35,2 | %2,9 | %0,3 | 8/10 |
| AMGNAmgen | 26,3 | 19,7 | 24,0 | %4,4 | %2,3 | 6/10 |
| GILDGILEAD | — | 16,1 | — | %6,8 | %2,1 | 4/10 |
| ABTAbbott | 28,5 | 3,4 | 26,8 | %4,1 | %3,0 | 5/10 |
| PFEPfizer | 38,4 | 2,0 | — | %6,6 | %5,9 | 1/10 |
Fiscal-year history
From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.
Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 Haz 2026 · filed 30 Tem 2026
Buradan sözleşmeden çıkın · AB tüketicileri: Bir satın alma işlemini iptal etmek için 14 gün.